BIENAIME JEAN JACQUES

SEC Form 4 insider
Ascendis Pharma A/S ($ASND), Keros Therapeutics, Inc. ($KROS)
1 thesis · first seen Aug 19, 2026
WindowThesesResolvedWinsWin rateAvg returnMedian return
1d111100%+4.3%+4.3%
3d111100%+1.8%+1.8%
1w111100%+1.7%+1.7%
1m000———
3m000———
6m000———
1y000———

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$ASNDSEC Form 4bullish
BIENAIME JEAN JACQUES · Ascendis Pharma A/S · 45d agono track record yet
Long 2,000 shares of ASND
Bought 2,000 @ $246.33 avg · $492,654 · 2026-08-14

Form 4: BIENAIME JEAN JACQUES bought ASND

BIENAIME JEAN JACQUES (Director at Ascendis Pharma A/S) reported an open-market purchase of 2,000 shares of ASND at an average $246.33, roughly $492,654, in a Form 4 filed 2026-08-18.

At post $248.85Now $227.87-8.4% since postedas of Oct 2, 4:30 PM ET
1d+4.3%
3d+1.8%
1w+1.7%
1m-3.9%
3m—
6m—
1y—
View filing on SEC.gov →

End of results.